# Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update
Canonical URL: https://biopharmsignal.com/news/RIGL/rigel-announces-conference-call-and-webcast-to-report-fourth-quarter-and-full-year-2025-financial-results-and-business-update
Ticker: RIGL
Company: Rigel Pharmaceuticals
Source: Rigel Pharmaceuticals
Published: 2026-02-24 13:05 EST
Original Source URL: https://www.rigel.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-07-28 12:05 EST — [Rigel Announces Conference Call and Webcast to Report Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/RIGL/rigel-announces-conference-call-and-webcast-to-report-second-quarter-2026-financ-5b987d7a) — Source: Rigel Pharmaceuticals
- 2026-07-01 12:05 EST — [Rigel Appoints Board Member Alison L. Hannah, M.D. as Chief Medical Officer](https://biopharmsignal.com/news/RIGL/rigel-appoints-board-member-alison-l-hannah-m-d-as-chief-medical-officer-c2f47409) — Source: Rigel Pharmaceuticals
- 2026-06-16 20:01 EST — [Rigel Announces Closing of Licensing Agreement for VEPPANU™ (vepdegestrant)](https://biopharmsignal.com/news/RIGL/rigel-announces-closing-of-licensing-agreement-for-veppanu-vepdegestrant-31709183) — Source: Rigel Pharmaceuticals
- 2026-05-27 12:05 EST — [Rigel to Present at the Jefferies Global Healthcare Conference](https://biopharmsignal.com/news/RIGL/rigel-to-present-at-the-jefferies-global-healthcare-conference) — Source: Rigel Pharmaceuticals
- 2026-05-21 21:17 EST — [Rigel Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting and EHA2026 Congress](https://biopharmsignal.com/news/RIGL/rigel-announces-oral-and-poster-presentations-at-the-2026-asco-annual-meeting-and-eha2026-congress) — Source: Rigel Pharmaceuticals
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)